Deals
PAI- backed Chr Hansen to float in Copenhagen
PAI partners portfolio company Chr Hansen is to list on the NASDAQ OMX Copenhagen stock exchange. The Danish food ingredients group’s IPO is said to be fully subscribed and is expected to raise DKK 3.16bn.
Centocor acquires RespiVert from Advent
Advent Venture Partners and other investors have sold their stakes in drug discovery company RespiVert.
Diet Chef receives £3m from Piper Private Equity
Diet Chef, the UK-based diet meals delivery company, has received £3m from Piper Private Equity to expand its operations.
Investinor et al. invest $4.2m in ExproSoft AS
Norwegian private equity funds Investinor and Viking Venture have acquired a 42.3% share of ExproSoft AS.
PAI Partners looking to sell Kwik-Fit
PAI is believed to have put Kwik-Fit's car-repair operation up for auction, looking for £250m. It's insurance branch already on the market.
Catapult invests £1.1m in Biofortuna
Catapult Venture has invested £1.1m into a molecular diagnostics company Biofortuna Ltd.
AGF Private Equity becomes IDInvest Partners
IDI Group has finalised the buyout of French private equity firm AGF from Allianz.
Southern Europe: Investing in family value
Investindustrial's Carlo Umberto Bonomi speaks to Francinia Protti-Alvarez about the private equity market in Spain and Italy. He says the market is extremely promising, despite having faced difficulties in recent years.
Finance Wales backs AssayMetrics
Finance Wales has led an early-stage investment in UK biotechnology company AssayMetrics. No financial details have been disclosed.
Darwin buys Plum Baby
Darwin Private Equity has acquired UK food producer, Plum Baby, for £10m.
AAC Capital buys UK pharma company for £100m
Martindale Pharmaceuticals, the UK based methadone maker, has been bought by AAC Capital Partners for £100m.
NewVoiceMedia gets £4m boost from Eden Ventures and Notion Capital
Eden Ventures and Notion Capital have provided £4m in expansion capital to UK technology vendor, NewVoiceMedia.
NorthStar leads £1.6m investment in Reinnervate
NorthStar Equity Investors has led a £1.6m funding round for start-up biotechnology company, Reinnervate.
Energy Ventures et al. invest £3.15m in Stingray Geophysical
Oil equipment and services company Stingray Geophysical has secured a £3.15m investment from its existing shareholders Energy Ventures, Cody Gates Ventures, Chevron Technology Ventures and Statoil Ventures. Management also took part in the transaction.
Leverage: The return of warehoused debt
The $400m asset-backed warehouse facility used to back last week’s buyout of aircraft leasing company, Avolon, signalled a further thawing of the corporate loan market. However, it remains to be seen whether the revival will lead to a reversal of a...
Perfectis sells Louisiane to Finadorm
Perfectis Private Equity has sold its controlling stake in mobile home manufacturer Louisiane to the Finadorm Group for an undisclosed sum.
NGN Capital leads €33m series-D round for NOXXON Pharma AG
NGN Capital has led a €33m series-D round in NOXXON Pharma. NGN is a new investor and was joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow...
AGF injects €12m in online poker company
AGF Private Equity has invested €12m in online-gaming company Winamax Holdings.
NorthStar leads £1.6m round in Reinnervate
NorthStar Equity Investors has led an investment round of over £1.6m in biotech start-up Reinnervate Limited.
Ventech invests €10m in Funxional Therapeutics
French private equity firm Ventech entered the series-B financing round as a new investor, alongside existing backers Index Ventures and Novo A/S.
Warburg Pincus drops out of RBS WorldPay sale
Warburg Pincus has reportedly dropped out of bidding to buy Royal Bank of Scotland’s (RBS) WorldPay division.
Quilvest invests €4m in social media firm Vanksen
Luxembourg-based private equity firm Quilvest group has invested €4m into marketing communications agency Vanksen.
Sarsia Seed invests in APIM Therapeutics
Sarsia Seed has invested NOK 3.5m in Norwegian drug developer, APIM Therapeutics AS.
Environmental investment: The many shades of green
Defining the environmental sector is not straightforward, as it overlaps with more ‘traditional’ sectors. The diversity of products and services that can be directly, or indirectly, categorised environmental technology goes well beyond the realm of...